Search details
1.
Vaccination induces broadly neutralizing antibody precursors to HIV gp41.
Nat Immunol
; 25(6): 1073-1082, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38816615
2.
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model.
Cell
; 183(4): 1058-1069.e19, 2020 11 12.
Article
in English
| MEDLINE | ID: mdl-33058755
3.
Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G.
Cell
; 165(4): 813-26, 2016 May 05.
Article
in English
| MEDLINE | ID: mdl-27114034
4.
Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity.
Immunity
; 53(6): 1272-1280.e5, 2020 12 15.
Article
in English
| MEDLINE | ID: mdl-33242394
5.
A Neutralizing Antibody Recognizing Primarily N-Linked Glycan Targets the Silent Face of the HIV Envelope.
Immunity
; 48(3): 500-513.e6, 2018 03 20.
Article
in English
| MEDLINE | ID: mdl-29548671
6.
A cross-neutralizing antibody between HIV-1 and influenza virus.
PLoS Pathog
; 17(3): e1009407, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33750987
7.
A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody.
PLoS Pathog
; 16(12): e1009089, 2020 12.
Article
in English
| MEDLINE | ID: mdl-33275640
8.
Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses.
Cell Host Microbe
; 31(1): 97-111.e12, 2023 01 11.
Article
in English
| MEDLINE | ID: mdl-36347257
9.
Neutralizing Antibody Response to Sarbecovirus Is Delayed in Sequential Heterologous Immunization.
Viruses
; 14(7)2022 06 24.
Article
in English
| MEDLINE | ID: mdl-35891363
10.
Neutralizing Antibodies to SARS-CoV-2 Selected from a Human Antibody Library Constructed Decades Ago.
Adv Sci (Weinh)
; 9(1): e2102181, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34716683
11.
Broadly neutralizing antibodies target the coronavirus fusion peptide.
bioRxiv
; 2022 Apr 12.
Article
in English
| MEDLINE | ID: mdl-35441178
12.
Broadly neutralizing antibodies target the coronavirus fusion peptide.
Science
; 377(6607): 728-735, 2022 08 12.
Article
in English
| MEDLINE | ID: mdl-35857439
13.
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants.
Science
; 373(6556): 818-823, 2021 08 13.
Article
in English
| MEDLINE | ID: mdl-34016740
14.
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants.
bioRxiv
; 2021 Feb 17.
Article
in English
| MEDLINE | ID: mdl-33619487
15.
A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection.
bioRxiv
; 2021 Feb 12.
Article
in English
| MEDLINE | ID: mdl-33594361
16.
Diverse immunoglobulin gene usage and convergent epitope targeting in neutralizing antibody responses to SARS-CoV-2.
Cell Rep
; 35(6): 109109, 2021 05 11.
Article
in English
| MEDLINE | ID: mdl-33932326
17.
A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection.
Cell Host Microbe
; 29(5): 806-818.e6, 2021 05 12.
Article
in English
| MEDLINE | ID: mdl-33894127
18.
A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody.
bioRxiv
; 2020 Sep 21.
Article
in English
| MEDLINE | ID: mdl-32995788
19.
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV.
Science
; 368(6491): 630-633, 2020 05 08.
Article
in English
| MEDLINE | ID: mdl-32245784
20.
An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain.
Cell Rep
; 33(3): 108274, 2020 10 20.
Article
in English
| MEDLINE | ID: mdl-33027617